KOLOA, Hawaii — Step therapy, an insurance protocol requiring patients to try and fail certain drugs before allowing access to other therapies, creates unnecessary collateral damage for practices and patients, according to a speaker here.
“Step therapy is onerous, and it interferes with our ability to pick and do the best for the patient in the chair. That is what this all boils down to,” Allen C. Ho, MD, said at Hawaiian Eye 2020.
Delaying needed drugs due to step therapy policies can be compromising. A patient with diabetic macular (Read more...)